Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
Chandima Jeewandara, Achala Kamaladasa, Pradeep Darshana Pushpakumara, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 31
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
COVID-19 Vaccinations: A Comprehensive Review of Their Safety and Efficacy in Special Populations
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Vaccines (2021) Vol. 9, Iss. 10, pp. 1097-1097
Open Access | Times Cited: 39
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
Thomas Perkmann, Patrick Mucher, Nicole Perkmann‐Nagele, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo Du, Huaichuan Duan, Yan Cheng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
Philipp Girl, Katrin Zwirglmaier, Heiner von Buttlar, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 18
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Pulmonary Delivery of Nonviral Nucleic Acid‐Based Vaccines With Spotlight on Gold Nanoparticles
Carolina Araujo Cirne, Marianna Földvári
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Open Access
The magnitude and cross reactivity of SARS-CoV-2 specific antibody responses in Sri Lankan children and association with the nutritional status
Chandima Jeewandara, Maneshka Vindesh Karunananda, Suranga Fernando, et al.
Research Square (Research Square) (2025)
Closed Access
Post-Omicron SARS-CoV-2 antibody prevalence in Sierra Leone: A cross-sectional, nationally representative, follow-up serosurvey
Smit Chitre, Mohamed Bailor Barrie, Joseph Sam Kanu, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004273-e0004273
Open Access
Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
Joanna Szczepanek, Monika Skorupa, Agnieszka Goroncy, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 99-99
Open Access | Times Cited: 16
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
Helen Forgham, Aleksandr Käkinen, Ruirui Qiao, et al.
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 15
Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
Padmanabha Shenoy, Sakir Ahmed, Aby Paul, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e80-e82
Open Access | Times Cited: 19
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
Chandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, et al.
Immunology (2022) Vol. 167, Iss. 2, pp. 263-274
Open Access | Times Cited: 14
Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals
Ji Young Hwang, Yunhwa Kim, Kyung‐min Lee, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 332-332
Open Access | Times Cited: 13
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
Immunology (2022) Vol. 167, Iss. 2, pp. 275-285
Open Access | Times Cited: 13
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
Chandima Jeewandara, Suranga Fernando, Pradeep Darshana Pushpakumara, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 2
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
Chandima Jeewandara, Inoka Sepali Aberathna, Laksiri Gomes, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 11
To be remembered: B cell memory response against SARS‐CoV‐2 and its variants in vaccinated and unvaccinated individuals
Nafees Ahmed, Atharv Athavale, Ankita Tripathi, et al.
Scandinavian Journal of Immunology (2023) Vol. 99, Iss. 2
Open Access | Times Cited: 5
Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre
Anuja Desai, Parth Desai, Jigar Mehta, et al.
International Journal of Infectious Diseases (2021) Vol. 113, pp. 282-287
Open Access | Times Cited: 10
Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers
Hamed Zare, Hadis Rezapour, Alireza Fereidouni, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top